338 related articles for article (PubMed ID: 9564051)
1. Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
Reil H; Bukovsky AA; Gelderblom HR; Göttlinger HG
EMBO J; 1998 May; 17(9):2699-708. PubMed ID: 9564051
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
Lee PP; Linial ML
J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
[TBL] [Abstract][Full Text] [Related]
4. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
[TBL] [Abstract][Full Text] [Related]
6. Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy.
Wang JJ; Lu Y; Ratner L
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2607-14. PubMed ID: 7931147
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
8. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
[TBL] [Abstract][Full Text] [Related]
9. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
13. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
14. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
15. Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein.
Ratner L; Vander Heyden N; Garcia J; Polinsky M; Westervelt P; Becich M
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):287-94. PubMed ID: 1829617
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
Di Marzio P; Choe S; Ebright M; Knoblauch R; Landau NR
J Virol; 1995 Dec; 69(12):7909-16. PubMed ID: 7494303
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 replication.
Freed EO
Somat Cell Mol Genet; 2001 Nov; 26(1-6):13-33. PubMed ID: 12465460
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.
Fouchier RA; Meyer BE; Simon JH; Fischer U; Malim MH
EMBO J; 1997 Aug; 16(15):4531-9. PubMed ID: 9303297
[TBL] [Abstract][Full Text] [Related]
19. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Novikova M; Ablan SD; Freed EO
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
